Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RESILIENCE: Effect of Comprehensive Celecoxib Through Treatment for Advanced-Stage Head and Neck Cancer: A Randomized, Double-Blinded, Placebo-Controlled Trial

NCT04162873 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT04162873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04162873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RESILIENCE: Effect of Comprehensive Celecoxib Through Treatment for Advanced-Stage Head and Neck Cancer: A Randomized, Double-Blinded, Placebo-Controlled Trial
Lead sponsor
University of Utah
Phase
Phase 2
Overall status
Terminated
Start date
November 27, 2019
Completion date
April 26, 2023
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, clinical stage iv hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, nasal cavity and paranasal sinus carcinoma, oral cavity carcinoma, pathologic stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, pathologic stage iv hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8, recurrent hypopharyngeal carcinoma, recurrent laryngeal carcinoma, recurrent nasal cavity and paranasal sinus carcinoma, recurrent oral cavity carcinoma, recurrent oropharyngeal carcinoma, stage iii hypopharyngeal carcinoma ajcc v8, stage iii laryngeal cancer ajcc v8, stage iii oropharyngeal (p16-negative) carcinoma ajcc v8, stage iv hypopharyngeal carcinoma ajcc v8, stage iv laryngeal cancer ajcc v8, stage iv oropharyngeal (p16-negative) carcinoma ajcc v8, stage iva hypopharyngeal carcinoma ajcc v8, stage iva laryngeal cancer ajcc v8, stage iva oropharyngeal (p16-negative) carcinoma ajcc v8, stage ivb hypopharyngeal carcinoma ajcc v8, stage ivb laryngeal cancer ajcc v8, stage ivb oropharyngeal (p16-negative) carcinoma ajcc v8, stage ivc hypopharyngeal carcinoma ajcc v8, stage ivc laryngeal cancer ajcc v8, stage ivc oropharyngeal (p16-negative) carcinoma ajcc v8